A detailed history of California State Teachers Retirement System transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 40,767 shares of TNGX stock, worth $123,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,767
Previous 42,144 3.27%
Holding current value
$123,931
Previous $361,000 13.3%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.36 - $11.93 $10,134 - $16,427
-1,377 Reduced 3.27%
40,767 $313,000
Q2 2024

Aug 14, 2024

BUY
$6.66 - $10.15 $6,626 - $10,099
995 Added 2.42%
42,144 $361,000
Q1 2024

May 15, 2024

SELL
$7.51 - $12.88 $18,016 - $30,899
-2,399 Reduced 5.51%
41,149 $326,000
Q4 2023

Feb 13, 2024

SELL
$6.52 - $12.01 $43,918 - $80,899
-6,736 Reduced 13.4%
43,548 $431,000
Q3 2023

Nov 14, 2023

SELL
$2.93 - $11.26 $32,572 - $125,177
-11,117 Reduced 18.11%
50,284 $566,000
Q2 2023

Aug 21, 2023

BUY
$2.67 - $4.7 $4,101 - $7,219
1,536 Added 2.57%
61,401 $203,000
Q1 2023

May 09, 2023

SELL
$3.76 - $8.06 $3,019 - $6,472
-803 Reduced 1.32%
59,865 $236,000
Q4 2022

Feb 14, 2023

BUY
$3.41 - $8.29 $53,864 - $130,948
15,796 Added 35.2%
60,668 $439,000
Q3 2022

Nov 18, 2022

SELL
$3.25 - $5.46 $3,695 - $6,208
-1,137 Reduced 2.47%
44,872 $162,000
Q2 2022

Aug 15, 2022

BUY
$3.86 - $8.01 $47,991 - $99,588
12,433 Added 37.03%
46,009 $208,000
Q1 2022

May 16, 2022

BUY
$7.01 - $10.94 $2,285 - $3,566
326 Added 0.98%
33,576 $255,000
Q4 2021

Feb 15, 2022

BUY
$9.55 - $14.29 $317,537 - $475,142
33,250 New
33,250 $364,000

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $268M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.